The current INKT market cap is 31.76M. The company's latest EPS is USD -0.6506 and P/E is -1.35.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -7.99M | -7.89M | -5.85M | -6.34M | -5.22M |
Net Income | -6.33M | -7.77M | -5.69M | -6.2M | -5.12M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.2M | 0 | 0 | 0 | 0 |
Operating Income | -22.28M | -14.64M | -28.36M | -30.95M | -22.92M |
Net Income | -23.8M | -16.24M | -30.21M | -27.99M | -22.46M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 25.26M | 21.47M | 16.59M | 12.11M | 7.46M |
Total Liabilities | 18.51M | 21.87M | 21.07M | 21.61M | 21.04M |
Total Equity | 6.76M | -401k | -4.48M | -9.5M | -13.58M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.31M | 4.56M | 40.24M | 21.47M | 4.55M |
Total Liabilities | 37.64M | 58.43M | 16.47M | 21.87M | 22.61M |
Total Equity | -36.33M | -53.87M | 23.78M | -401k | -18.06M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.44M | -18.87M | -4.37M | -8.52M | -12.73M |
Investing | -122k | -250k | -14k | -51k | -74k |
Financing | -156k | -155k | -335k | -410k | -408k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.94M | -8.34M | -12.83M | -18.87M | -15.76M |
Investing | -426k | -95k | -249k | -250k | -74k |
Financing | 11.44M | 11.11M | 49.26M | -155k | -407k |
Market Cap | 31.76M |
Price to Earnings Ratio | -1.35 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 9.03 |
Price to Book Ratio | -1.68 |
Dividend Yield | - |
Shares Outstanding | 34.52M |
Average Volume (1 week) | 48k |
Average Volume (1 Month) | 197.48k |
52 Week Change | -56.39% |
52 Week High | 3.34 |
52 Week Low | 0.75 |
Spread (Intraday) | 0.06 (6.49%) |
Company Name | MiNK Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://minktherapeutics.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.